Immunocore MAGE-A4 Investor & Analyst Event 2021
Please join Immunocore for an upcoming Investor & Analyst event focused on the initial Phase 1 MAGE-A4 study.
The call will feature Dr. Diwakar Davar, University of Pittsburgh Medical Center.
Diwakar Davar, MBBS, M.Sc is an assistant professor of medicine and a medical oncologist/hematologist. He specializes in the management of advanced melanoma and the development of early phase studies to test novel immunotherapeutic approaches to treat advanced cancers. Dr. Davar is board-certified in internal medicine and medical oncology. He received his medical degree from National University of Singapore, and completed both his residency and fellowship at UPMC.
For more information or questions please reach out to William Windham (firstname.lastname@example.org)